Institutional Ownership Revolution Medicines, Inc. (RVMD)
This table provides information about the institutional ownership of Revolution Medicines, Inc. (RVMD). We have compiled data on the 298 institutions that hold shares in the stock, with a total of 168 Million shares, which have been reported (via 13F filing form) to have a value of $6.63 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
17,096,455
shares
|
$657 Million
0.01% of portfolio
|
Q4 2024
Added 14.65%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,408,713
shares
|
$516 Million
0.01% of portfolio
|
Q2 2024
Added 8.94%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
13,248,692
shares
|
$509 Million
3.09% of portfolio
|
Q4 2024
Added 17.06%
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
9,483,999
shares
|
$365 Million
0.22% of portfolio
|
Q4 2024
Added 54.53%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
7,936,972
shares
|
$305 Million
3.85% of portfolio
|
Q4 2024
Added 4.86%
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
7,601,087
shares
|
$292 Million
61.97% of portfolio
|
Q4 2024
Added 20.71%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
6,553,111
shares
|
$252 Million
10.94% of portfolio
|
Q4 2024
Added 23.32%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
5,865,962
shares
|
$226 Million
0.03% of portfolio
|
Q4 2024
Added 10.4%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
5,791,752
shares
|
$223 Million
0.01% of portfolio
|
Q4 2024
Added 9.7%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
4,386,900
shares
|
$169 Million
3.82% of portfolio
|
Q4 2024
Reduced 9.95%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,181,179
shares
|
$161 Million
6.84% of portfolio
|
Q4 2024
Added 20.2%
|
|
|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
4,133,277
shares
|
$159 Million
12.77% of portfolio
|
Q4 2024
Reduced 2.89%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
4,086,199
shares
|
$157 Million
0.01% of portfolio
|
Q4 2024
Added 12.66%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,885,713
shares
|
$149 Million
1.26% of portfolio
|
Q4 2024
Added 13.16%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
3,829,349
shares
|
$147 Million
0.01% of portfolio
|
Q4 2024
Reduced 7.46%
|
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
3,699,283
shares
|
$142 Million
13.92% of portfolio
|
Q4 2024
Reduced 10.09%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
3,258,332
shares
|
$125 Million
3.53% of portfolio
|
Q4 2024
Added 11.87%
|
|
|
Holocene Advisors, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,996,710
shares
|
$115 Million
0.45% of portfolio
|
Q4 2024
Added 39.41%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,630,152
shares
|
$101 Million
0.02% of portfolio
|
Q4 2024
Added 11.7%
|
|
|
Lunate Holding Rsc LTD
Al Maryah Island, Abu Dhabi, C0 |
Feb 14, 2025 Q4 2024 |
2,196,200
shares
|
$84.4 Million
45.54% of portfolio
|
Q4 2024
New holding
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Feb 14, 2025 Q4 2024 |
1,978,720
shares
|
$76.1 Million
0.27% of portfolio
|
Q4 2024
Added 8.01%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,931,114
shares
|
$74.3 Million
0.02% of portfolio
|
Q4 2024
Added 9.53%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
1,742,039
shares
|
$67 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
1,678,434
shares
|
$64.5 Million
1.27% of portfolio
|
Q4 2024
Added 25.93%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
1,626,848
shares
|
$62.6 Million
0.02% of portfolio
|
Q4 2024
Added 9.52%
|